Bivalent single-domain antibodies show potent mpox virus neutralization through M1R antigen
Abstract Despite the recent mpox outbreak raising global concerns, no fully validated antiviral treatment exists, highlighting the urgent need for effective therapeutics. Here, by taking advantage of the preparation technology for single-domain (VHH) antibodies, we generated VHHs targeting the six m...
Saved in:
| Main Authors: | Daisuke Akazawa, Masayuki Shimojima, Eun-Sil Park, Akiko Okutani, Milagros Virhuez-Mendoza, Yusuke Inoue, Takayuki Hishiki, Ken Maeda, Hideki Ebihara, Yoshimasa Takahashi, Koichi Watashi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Communications Biology |
| Online Access: | https://doi.org/10.1038/s42003-025-08494-x |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
MPox Skin Lesions
by: Robert Sinto, et al.
Published: (2024-04-01) -
Exploring the Potential Treatment for Mpox
by: Kevin Kevin, et al.
Published: (2024-10-01) -
Bivalent Carbon Dioxide Heat Pump for Heating Multi-Storey Buildings
by: Sit M.L., et al.
Published: (2023-05-01) -
Mathematical modeling to understand the role of bivalent thrombin-fibrin binding during polymerization.
by: Michael A Kelley, et al.
Published: (2022-09-01) -
Mpox: A narrative review on current knowledge
by: Jun-Yuan Zheng, et al.
Published: (2025-08-01)